Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | BNT113 |
Synonyms | |
Therapy Description |
BNT113 is an RNA vaccine that consists of liposome encapsulated HPV-16 viral proteins E6 and E7, which may lead to activation of T lymphocyte mediated immune response against HPV-16 E6 and E7-positive tumor cells (NCI Drug Dictionary) |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
BNT113 | BNT-113|BNT 113|E6/E7 RNA(LIP) BNT113|RNA-lipoplex Cancer Vaccine BNT113 | BNT113 is an RNA vaccine that consists of liposome encapsulated HPV-16 viral proteins E6 and E7, which may lead to activation of T lymphocyte mediated immune response against HPV-16 E6 and E7-positive tumor cells (NCI Drug Dictionary) |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT03418480 | Phase Ib/II | BNT113 | HPV Anti-CD40 RNA Vaccine (HARE-40) | Completed | GBR | 0 |